Publications in the NUM
Here you will find a list of publications that were written in connection with the Network of University Medicine in the first and second funding phases.
Tafforeau P,
Wagner W,
et al .
The Bronchial Circulation in COVID-19 Pneumonia.
Am J Respir Crit Care Med.
2022;
205121-125.
[DOI]
Prokosch H,
Bahls T,
Bialke M,
Eils J,
Fegeler C,
Gruendner J,
Haarbrandt B,
Hampf C,
Hoffmann W,
Hund H,
Kampf M,
Kapsner LA,
Kasprzak P,
Kohlbacher O,
Krefting D,
Mang JM,
Marschollek M,
Mate S,
Müller A,
Prasser F,
Sass J,
Semler S,
Stenzhorn H,
Thun S,
Zenker S,
Eils R.
The COVID-19 Data Exchange Platform of the German university
medicine.
Stud. Health Technol. Inform..
2022 May;
294674—678.
Schons M,
Pilgram L,
Reese J,
Stecher M,
Anton G,
Appel KS,
Bahmer T,
Bartschke A,
Bellinghausen C,
Bernemann I,
Brechtel M,
Brinkmann F,
Brünn C,
Dhillon C,
Fiessler C,
Geisler R,
Hamelmann E,
Hansch S,
Hanses F,
Hanß S,
Herold S,
Heyder R,
Hofmann A,
Hopff SM,
Horn A,
Jakob C,
Jiru-Hillmann S,
Keil T,
Khodamoradi Y,
Kohls M,
Kraus M,
Krefting D,
Kunze S,
Kurth F,
Lieb W,
Lippert LJ,
Lorbeer R,
Lorenz-Depiereux B,
Maetzler C,
Miljukov O,
Nauck M,
Pape D,
Püntmann V,
Reinke L,
Römmele C,
Rudolph S,
Sass J,
Schäfer C,
Schaller J,
Schattschneider M,
Scheer C,
Scherer M,
Schmidt S,
Schmidt J,
Seibel K,
Stahl D,
Steinbeis F,
Störk S,
Tauchert M,
Tebbe JJ,
Thibeault C,
Toepfner N,
Ungethüm K,
Vadasz I,
Valentin H,
Wiedmann S,
Zoller T,
Nagel E,
Krawczak M,
Kalle C,
Illig T,
Schreiber S,
Witzenrath M,
Heuschmann P,
Vehreschild JJ,
Group NR.
The German National Pandemic Cohort Network (NAPKON):
rationale, study design and baseline characteristics.
Eur. J. Epidemiol..
2022 Aug.;
37(8):849—870.
[DOI]
[Pubmed]
Borusiak P,
Mazheika Y,
Bauer S,
Haberlandt E,
Krois I,
Fricke C,
Simon L,
Beschoner P,
Jerg-Bretzke L,
Geiser F,
Hiebel N,
Weidner K,
Morawa E,
Erim Y.
The impact of the COVID-19 pandemic on pediatric developmental services: a cross-sectional study on overall burden and mental health status.
Arch Public Health.
2022;
80(1):113.
Hannemann J,
Erim Y,
Morawa E,
Jerg-Bretzke L,
Beschoner P,
Geiser F,
Hiebel N,
Weidner K,
Steudte-Schmiedgen S.
The impact of the COVID-19 pandemic on the mental health of medical staff considering the interplay of pandemic burden and psychosocial resources-A rapid systematic review.
PLoS One.
2022;
17(2):e0264290.
[DOI]
Schreiber A,
Viemann D,
Schöning J,
Schloer S,
Mecate Zambrano A,
Brunotte ea.
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
Cell Mol Life Sci.
2022;
7965.
[DOI]
Wratil PR,
Stern M,
Priller A,
et al .
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern.
Nat Med.
2022;
[DOI]
Voigtlaender M,
Edler C,
Gerling M,
Schädler J,
Ondruschka B,
Schröder AS,
Sperhake J,
Ehrhardt S,
Wang L,
Haddad M,
Kiencke V,
Renné T,
Roedl K,
Kluge S,
Wichmann D,
Länger F.
Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors.
Thrombosis Research.
2022 Oct.;
218171—176.
[DOI]
[File]
Kamp JC,
Neubert L,
Stark H,
Werlein C,
Fuge J,
Haverich A,
Tzankov A,
Steinestel K,
Friemann J,
Boor P,
Junker K,
Hoeper MM,
Welte T,
Laenger F,
Kuehnel MP,
Jonigk DD.
Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19.
International Journal of Molecular Sciences.
2022 Jan.;
23(3):1583.
[DOI]
Kamp J,
Neubert L,
et al .
Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19.
Int J Mol Sci.
2022;
23
[DOI]
Wulff A,
Biermann P,
Landesberger T,
Baumgartl T,
Schmidt C,
Schick K,
Waldstein P,
Zhu Y,
Krefting D,
Scheithauer S,
Marschollek M.
Tracing COVID-19 Infection Chains Within Healthcare Institutions - Another Brick in the Wall Against SARS-CoV-2.
Studies in health technology and informatics.
2022;
290699—703.
[DOI]
Schug C,
Erim Y,
Geiser F,
Hiebel N,
Beschoner P,
Jerg-Bretzke L,
Weidner K,
Steudte-Schmiedgen S,
Borho A,
Lieb M,
Morawa E.
Vaccination willingness against COVID-19 among healthcare workers in Germany: Results from a University Medicine Network survey between November 2020 and January 2021.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.
2022 Jan.;
65(1):74—85.
[DOI]
[File]
Struwe C,
Golinski M,
Grimm C,
Dickel S,
Grummich K,
Nothacker M,
Voigt-Radloff S,
Meerpohl J,
Moerer O.
Vergleich und Bewertung internationaler Leitlinien zur Behandlung schwerer Verläufe von SARS-CoV-2-Infektionen.
Dtsch Arztebl Int.
2022;
11923-30.
[DOI]
Mayer K.
Pandemic Disruptions and Transnational Care Relations: Towards Closing the “Care Gap” in International Relations Theories. In:
Gephart, W, editors.
In the Realm of Corona Normativities II.
Verlag Vitorrio Klostermann;
2022.
Dickel S,
Grimm C,
Popp M,
Struwe C,
Sachkova A,
Golinski M,
Seeber C,
Fichtner F,
Heise D,
Kranke P,
Meissner W,
Laudi S,
Voigt-Radloff S,
Meerpohl J,
Moerer O,
Group On Behalf Of The German CEOsys Study .
A Nationwide Cross-Sectional Online Survey on the Treatment of COVID-19-ARDS: High Variance in Standard of Care in German ICUs.
J Clin Med.
2021 Jul. 29;
10(15):3363.
[DOI]
Grimm C,
Dickel S,
Sachkova A,
Popp M,
Golinksi M,
Fichtner F,
Kranke P,
Seeber C,
Laudi S,
Voigt-Radloff S,
Moerer O.
Targeted Minimal Staff-to-Patient Ratios Are Unachievable - A Nationwide Survey in German ICUs During the COVID-19 Pandemic.
Cureus.
2021 Jun. 19;
13(6):e15755.
[DOI]
Holzmann-Littig C,
Braunisch MC,
Kranke P,
Popp M,
Seeber C,
Fichtner F,
Littig B,
Carbajo-Lozoya J,
Frank T,
Meerpohl JJ,
Haller B,
Schmaderer C.
COVID-19 Vaccination Acceptance and Hesitancy among Healthcare Workers in Germany.
Vaccines (Basel).
2021 Jul. 12;
9(7):777.
[DOI]
Jansky M,
Schade F,
Rieder N,
Lohrmann D,
Gebel C,
Stahl D.
‘It felt like a black hole, great uncertainty, but we have to take care for our patients’–Qualitative findings on the effects of the COVID-19 pandemic on specialist palliative home care.
PLOS ONE.
2021;
16(12):e0260767.
[DOI]
Schloesser K,
Simon ST,
Pauli B,
Stahl D.
“Saying goodbye all alone with no close support was difficult”- Dying during the COVID-19 pandemic: an online survey among bereaved relatives about end-of-life care for patients with or without SARS-CoV2 infection.
BMC Health Serv Res.
2021;
21(998):
[DOI]
Gebel C,
Kloppenburg L,
Jansky MK,
Nauck F,
Schade F,
Weddin U.
„Es waren Kreativität und Umdenken erforderlich.“ Auswirkungen der COVID-19 Pandemie auf die spezialisierte ambulante Palliativversorgung (SAPV). Eine bundesweite Onlinebefragung.
Gesundheitswesen.
2021;
[DOI]
Reichardt M,
Moller Jensen P,
et al .
3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography.
Elife.
2021;
10e71359.
[DOI]
Vesper N,
et al .
A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
Frontiers in immunology.
2021;
12
[DOI]
Iftekhar EN,
Priesemann V,
Balling R,
Bauer S,
Beutels P,
Valdez AC,
Cuschieri S,
Czypionla T,
Dumpis U,
Glaab E,
Grill E,
Hanson C,
Hotulainen P,
Klimek P,
Kretzschmar M,
Krüger T,
Krutzinna J,
Low N,
Machado H,
Martins C,
McKee M,
Mohr SB,
Nassehi A,
Perc M,
Petelos E,
Pickersgrill M,
Prainsack B,
Rocklöv J,
Schernhammer E,
Staines A,
Szczurek E,
Tsiodras S,
Van Gucht S,
Willeit P.
A look into the future of the COVID-19 pandemic in Europe: an expert consultation.
The Lancet Regional Health-Europe.
2021;
8100185.
[DOI]
Wang Z,
Cryar A,
Lemke O,
Ludwig D,
Tober-Lau P,
Helbig ea.
A multiplex protein panel assay determines disease severity and is prognostic about outcome in COVID-19 patients.
medRxiv.
2021;
[DOI]
Mahoney M,
et al .
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.
Proceedings of the National Academy of Sciences of the United States of America.
2021;
118
[DOI]
Peter AS,
et al .
A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model.
European journal of immunology.
2021;
[DOI]
Schuh W,
et al .
A surrogate cell-based SARS-CoV-2 spike blocking assay.
European journal of immunology.
2021;
[DOI]
Demichev V,
et al .
A time-resolved proteomic and prognostic map of COVID-19.
Cell Systems.
2021;
[DOI]
Demichev V,
Tober-Lau P,
Lemke O,
Nazarenko T,
Thibeault C,
Whitwell H,
Röhl A,
Freiwald A,
Szyrwiel L,
Ludwig D,
Stahl D.
A time-resolved proteomic and prognostic map of COVID-19.
Cell Syst.
2021;
12(8):780—794.e7.
[DOI]
Demichev V,
Tober-Lau P,
Lemke O,
Nazarenko T,
Thibeault C,
Whitwell ea.
A time-resolved proteomic and prognostic map of COVID-19.
Cell Syst.
2021;
12780—+.
Stanifer ML,
Boulant S.
Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 (BSL-3) Conditions.
JoVE.
2021;
(166):e62857.
[DOI]
Mürbe D,
Kriegel M,
Lange J,
et al .
Aerosol emission in professional singing of classical music.
Sci Rep.
2021;
11
[DOI]
Mürbe D,
Kriegel M,
Lange J,
et al .
Aerosol emission of adolescents voices during speaking, singing and shouting.
PLoS ONE.
2021;
16(2):
[DOI]
Schwartz J,
Reuters MC,
Schallenburger M,
Stahl D.
Allgemeine Palliativversorgung in Pandemiezeiten.
Onkologe.
2021;
27686-690.
[DOI]
Weber JP,
Tielker JM,
Kamandi N,
et al .
Ambulante Betreuung onkologischer Patienten in palliativer Behandlungssituation und ihrer Angehörigen in der COVID-19-Pandemie.
Onkologe.
2021;
27783-789.
[DOI]
Priesemann V,
Balling R,
Brinkmann MM,
Ciesek S,
Czypionka T,
Eckerle I,
Giordano G,
Hanson C,
Hel Z,
Hotulainen P,
Klimek P,
Nassehi A,
Peichl A,
Perc M,
Petelos E,
Prainsack B,
Szczurek E.
An action plan for pan-European defence against new SARS-CoV-2 variants.
The Lancet.
2021;
397(10273):469—470.
[DOI]
Bagheri G,
Thiede B,
Hejazi B,
et al .
An upper bound on one-to-one exposure to infectious human respiratory particles.
PNAS.
2021;
118(49):
[DOI]
Schulze J,
Mache C,
Balazs A,
Frey D,
Niemeyer D,
Olze ea.
Analysis of SARS-CoV-2 replication in explant cultures of the human upper respiratory tract reveals broad tissue tropism of wild-type and B.1.1.7 variant viruses.
J Infect Dis.
2021;
[DOI]
Renn M,
Bartok E,
Zillinger T,
Hartmann G,
Behrendt R.
Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.
Pharmacology & Therapeutics.
2021;
107931.
[DOI]
Gagiannis D,
Umathum VG,
Bloch W,
Rother C,
Stahl M,
Witte HM,
Djudjaj S,
Boor P,
Steinestel K.
Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2.
Am J Clin Pathol.
2021;
[DOI]
Popp M,
Stegemann M,
Riemer M,
Metzendorf M,
Romero CS,
Mikolajewska A,
Kranke P,
Meybohm P,
Skoetz N,
Weibel S.
Antibiotics for the treatment of COVID‐19.
Cochrane Database of Systematic Reviews.
2021;
2021CD015025.
[DOI]
Möller P,
Uzun G,
Singh A,
Beck A,
Bettag M,
Bösmüller H,
Guthoff M,
Dorn F,
Petzold GC,
Henkes H,
Heyne N,
Jumaa H,
Kreiser K,
Limpach C,
Luz B,
Maschke M,
Müller J,
Münch J,
Nagel S,
Pötzsch B,
Müller J,
Schlegel C,
Viardot A,
Bäzner H,
Wolf M,
Pelzl L,
Warm V,
Willinek WA,
Steiner J,
Schneiderhan-Marra N,
Vollherbst D,
Sachs UJ,
Fend F,
Bakchoul T.
Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia.
Haematologica.
2021 Aug.;
106(8):2170-2179.
[DOI]
Aschman T,
Schneider J,
Greuel S,
Meinhardt J,
Streit S,
Goebel ea.
Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.
JAMA Neurol.
2021;
78948—960.
Aschman T,
Schneider J,
Greuel S,
Meinhardt J,
Streit S,
Goebel H,
Büttnerova I,
Elezkurtaj S,
Scheibe F,
Radke J,
Meisel C,
Drosten C,
Radbruch H,
Heppner F,
Corman V,
Stenzel W.
Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.
JAMA Neurol.
2021 Aug.;
78(8):948-960.
[DOI]
Pogarell O,
Pröbstl L,
Rüb M,
Wiegand HF,
Tüscher O,
Lieb K,
Wassiliwizky E,
Gerlinger G,
Heinz A,
Falkai P.
Auswirkungen der COVID-19-Pandemie auf die Versorgungssituation in psychiatrischen Kliniken in Deutschland.
Der Nervenarzt.
2021;
92(6):562—570.
[DOI]